The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

InBrain Neuroelectronics announced today that it entered into a strategic collaboration with Microsoft to explore AI in ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Viewed as the next evolution of artificial intelligence (AI), agentic AI enables systems to act autonomously based on ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...